FDA approves first gene therapy for rare immune disorder
By Thomson ReutersDec 9, 2025 | 5:23 PM
Dec 9 (Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy for a rare and life-threatening immune disorder.
(Reporting by Sahil Pandey in Bengaluru; Editing by Maju Samuel)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
